Oral Health Implications of GLP-1 Receptor Agonists and Other Incretin-Based Therapies.
Researchers reviewed evidence on how GLP-1 receptor agonists and related diabetes and obesity drugs affect oral health, finding potential anti-inflammatory effects on gums alongside patient-reported complaints about mouth dryness, breath, and tooth problems, while calling for better monitoring in future studies.
A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.
Read the full study at the sourceRelated CPD from Vital Pulp
Vaping and Oral Health & Behaviour Change for Young People Who Vape
Two hours of evidence-graded CPD — what vaping does to the mouth, and how to have the conversation that actually lands.
The Recall — the month's most significant new dental research, summarised. Free.
Browse The Recall